TYRA
TYRA
NASDAQ · Biotechnology

Tyra Biosciences Inc

$26.60
+0.87 (+3.38%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -29.5% upside
Low Target $15.89
Average Target $18.74
High Target $31.24
Current Price $26.60
Current
$26.60
Target
$18.74
$15.89 $18.74 avg $31.24
Scenario Analysis
Bear Case
$15.89
-40.3%
Low target
Base Case
$18.74
-29.5%
Avg target
Bull Case
$31.24
+17.4%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$40.65
-34.6% from high
52-Week Low
$12.12
+119.6% from low
Target vs 52W High
$18.74
-53.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%